InMode to Present at Baird 2025 Global Healthcare Conference
Rhea-AI Summary
InMode (NASDAQ:INMD), a leading provider of innovative medical technologies, has announced its participation in the upcoming Baird 2025 Global Healthcare Conference. The company's CFO Yair Malca will engage in a fireside chat on September 10, 2025, at 8:30 AM ET in New York.
The presentation will be moderated by Baird's Senior Research Analyst Jeff Johnson and will be available via live webcast. Additionally, the company will conduct one-on-one meetings with investors during the conference.
Positive
- None.
Negative
- None.
News Market Reaction – INMD
On the day this news was published, INMD declined 3.55%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
YOKNEAM,
The fireside chat, moderated by Jeff Johnson, Senior Research Analyst, is scheduled for 8:30 am Eastern Time on Wednesday, Sept. 10, and a live webcast of the presentation can be accessed here. InMode will also hold one-on-one investor meetings in person that same day. To schedule a meeting, please contact your Baird representative.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 04, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/5329689/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-baird-2025-global-healthcare-conference-302541359.html
SOURCE InMode Ltd.
FAQ
When is InMode (INMD) presenting at the Baird 2025 Global Healthcare Conference?
Who will represent InMode at the Baird 2025 Healthcare Conference?
How can investors access InMode's presentation at the Baird conference?
Will InMode (INMD) be available for individual investor meetings at the Baird conference?
